Search research articles
Contact Us
Filters
Showing results (1-10 of 88) with videos related to
Page
of 9
Sort By:
Blood
|
April 15, 2017
Stopping bleeding is not enough to FIX hemarthropathy
Valder R Arruda
Revista Brasileira De Hematologia E Hemoterapia
|
October 10, 2013
A novel strategy for the screening for platelet refractoriness: prospects and limitations
Valder R Arruda
Haematologica
|
July 2, 2015
The search for the origin of factor VIII synthesis and its impact on therapeutic strategies for hemophilia A
Valder R Arruda
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 19, 2007
The role of immunosuppression in gene- and cell-based treatments for duchenne muscular dystrophy
Valder R Arruda
Blood Advances
|
October 26, 2021
Why is AAV FVIII gene therapy not approved by the US Food and Drug Administration yet?
Valder R Arruda
Thrombosis Research
|
June 12, 2012
The protein C pathway in cancer metastasis
C Arnold Spek, Valder R Arruda
Journal of Genetic Syndromes & Gene Therapy
|
June 3, 2014
Muscle Gene Therapy for Hemophilia
Denise E Sabatino, Valder R Arruda
Mediterranean Journal of Hematology and Infectious Diseases
|
September 21, 2020
Gene Therapy for Hemophilia: Facts and Quandaries in the 21st Century
Valder R Arruda, Bhavya S Doshi
Neuromuscular Disorders : NMD
|
March 28, 2008
Substantial immune suppression required in gene therapy for muscular dystrophy?
Roland W Herzog, Valder R Arruda
Therapeutic Advances in Hematology
|
September 14, 2018
Gene therapy for hemophilia: what does the future hold?
Bhavya S Doshi, Valder R Arruda
Page
of 9
Search research articles
Search
Showing results (1-10 of 88) with videos related to
Sort By:
Page
of 9
Blood
|
April 15, 2017
Stopping bleeding is not enough to FIX hemarthropathy
Valder R Arruda
Revista Brasileira De Hematologia E Hemoterapia
|
October 10, 2013
A novel strategy for the screening for platelet refractoriness: prospects and limitations
Valder R Arruda
Haematologica
|
July 2, 2015
The search for the origin of factor VIII synthesis and its impact on therapeutic strategies for hemophilia A
Valder R Arruda
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 19, 2007
The role of immunosuppression in gene- and cell-based treatments for duchenne muscular dystrophy
Valder R Arruda
Blood Advances
|
October 26, 2021
Why is AAV FVIII gene therapy not approved by the US Food and Drug Administration yet?
Valder R Arruda
Thrombosis Research
|
June 12, 2012
The protein C pathway in cancer metastasis
C Arnold Spek, Valder R Arruda
Journal of Genetic Syndromes & Gene Therapy
|
June 3, 2014
Muscle Gene Therapy for Hemophilia
Denise E Sabatino, Valder R Arruda
Mediterranean Journal of Hematology and Infectious Diseases
|
September 21, 2020
Gene Therapy for Hemophilia: Facts and Quandaries in the 21st Century
Valder R Arruda, Bhavya S Doshi
Neuromuscular Disorders : NMD
|
March 28, 2008
Substantial immune suppression required in gene therapy for muscular dystrophy?
Roland W Herzog, Valder R Arruda
Therapeutic Advances in Hematology
|
September 14, 2018
Gene therapy for hemophilia: what does the future hold?
Bhavya S Doshi, Valder R Arruda
Page
of 9